Top Buy
Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel ▼ | Potential |
---|---|---|---|---|---|---|---|
Alnylam Pharmace. | 36 | 0 | 2 | 0 | 137,60 € | 236,30 € | 71,73 % |
Insulet Corp. | 16 | 0 | 2 | 0 | 167,15 € | 215,54 € | 28,95 % |
Resmed Inc. | 19 | 0 | 3 | 0 | 200,70 € | 207,72 € | 3,50 % |
EssilorLuxottica SA | 3 | 0 | 0 | 0 | 208,50 € | 204,50 € | -1,92 % |
Zoetis Inc. A | 23 | 1 | 4 | 0 | 159,50 € | 200,06 € | 25,43 % |
Johnson & Johnson | 33 | 1 | 2 | 0 | 141,76 € | 195,83 € | 38,14 % |
Jazz Pharmaceuticals plc | 23 | 0 | 3 | 0 | 99,04 € | 184,92 € | 86,71 % |
Repligen Corp. | 13 | 0 | 1 | 0 | 153,75 € | 184,76 € | 20,17 % |
Krystal Biotech | 17 | 0 | 2 | 0 | 154,75 € | 179,60 € | 16,05 % |
AbbVie Inc. | 22 | 0 | 4 | 0 | 148,44 € | 175,11 € | 17,97 % |
Novo Nordisk A/S | 5 | 0 | 1 | 0 | 185,00 € | 170,00 € | -8,11 % |
AstraZeneca plc | 2 | 0 | 1 | 0 | 145,00 € | 165,00 € | 13,79 % |
Universal Health Services B | 10 | 3 | 1 | 0 | 166,00 € | 161,53 € | -2,69 % |
Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | 114,00 € | 150,00 € | 31,58 % |
Masimo Corp. | 7 | 1 | 1 | 0 | 106,75 € | 147,62 € | 38,28 % |
Merck KGaA | 3 | 1 | 0 | 0 | 168,20 € | 146,00 € | -13,20 % |
Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | 133,55 € | 144,44 € | 8,16 % |
Neurocrine Bioscience | 29 | 0 | 8 | 0 | 129,45 € | 140,60 € | 8,62 % |
Dexcom Inc. | 18 | 0 | 1 | 0 | 121,00 € | 136,82 € | 13,08 % |
Novo Nordisk A/S ADR | 16 | 1 | 0 | 0 | 124,00 € | 135,22 € | 9,05 % |
Agilent Technologies Inc. | 17 | 3 | 0 | 0 | 141,86 € | 134,50 € | -5,19 % |
Sarepta Therapeutics | 1 | 0 | 0 | 0 | 118,95 € | 130,00 € | 9,29 % |
Merck & Co. Inc. | 28 | 1 | 1 | 0 | 121,40 € | 124,93 € | 2,91 % |
Davita Inc. | 2 | 0 | 0 | 0 | 125,00 € | 124,89 € | -0,09 % |
Icu Medical Inc. | 3 | 0 | 0 | 0 | 94,00 € | 124,85 € | 32,82 % |